BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN BEGIN:VEVENT UID:129@biocityturku.fi DTSTART;TZID=Europe/Helsinki:20230207T140000 DTEND;TZID=Europe/Helsinki:20230207T150000 DTSTAMP:20231013T060328Z URL:https://biocityturku.fi/events/immunology-seminar-oneill-2/ SUMMARY:Immunology Seminar: O'Neill DESCRIPTION:February 7th at 14:00 – 15:00 (Finland time)\nVirtual event\n \nLuke O’Neill\, Trinity College Dublin:\nAdventures in Immunometabolism Research\n\nHost: Riitta Lahesmaa (rilahes@utu.fi )\n\n \;\n\nRegist ration latest February 6th at: https://link.webropolsurveys.com/S/C196B128 41386EFF \n\nImmunology seminar series is jointly organised by the Finnis h Society for Immunology\, InFLAMES Flagship and Turku Bioscience. For fur ther information contact Anne Lahdenperä (ankahy@utu.fi) or Riitta Lahesm aa (rilahes@utu.fi)\, University of Turku.\n\n \;\n\nLuke O’Neill i s Professor of Biochemistry in the School of Biochemistry and Immunology\, Trinity Biomedical Sciences Institute at Trinity College Dublin\, Ireland . He is a world expert on innate immunity and inflammation. His main resea rch interests include Toll-like receptors\, Inflammasomes and Immunometabo lism. He is listed by Thompson Reuters/ Clarivates in the top 1% of immuno logists in the world\, based on citations per paper. Professor O’Neill i s co-founder of Sitryx\, which aims to develop new medicines for inflammat ory diseases. Another company he co-founded\, Inflazome was recently acqui red by Roche.\n\nHe was awarded the Royal Dublin Society / Irish Times Boy le Medal for scientific excellence\, the Royal Irish Academy Gold Medal fo r Life Sciences\, The Society for Leukocyte Biology (SLB) Dolph O. Adams a ward\, the European Federation of Immunology Societies Medal\, the Milstei n Award of the International Cytokine and Interferon Society and the Lands teiner Award from the Austrian Academy of Sciences. He is a member of the Royal Irish Academy\, EMBO (European Molecular Biology Organisation) and a Fellow of the Royal Society.\n\n \;\n\nReferences\n\nRyan DG\, O’N eill LAJ Krebs Cycle Reborn in Macrophage Immunometabolism. Annu Rev Imm unol. 2020 Jan 27. doi: 10.1146/annurev-immunol-081619-104850\n\nO’Neil l LAJ\, Netea MG. BCG-induced trained immunity: can it offer protection a gainst COVID-19? Nat Rev Immunol. 2020 Jun\;20(6):335-337. doi: 10.1038/s 41577-020-0337-y.\n\nHooftman A\, Angiari S\, Hester S\, Corcoran SE\, Run tsch MC\, Ling C\, Ruzek MC\, Slivka PF\, McGettrick AF\, Banahan K\, Hugh es MM\, Irvine AD\, Fischer R\, O’Neill LAJ. The Immunomodulatory Meta bolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation. Cel l Metab. 2020 Sep 1\;32(3):468-478.e7. doi: 10.1016/j.cmet.2020.07.016.\n\ nRuntsch MC\, Angiari S\, Hooftman A\, Wadhwa R\, Zhang Y\, Zheng Y\, Spin a JS\, Ruzek MC\, Argiriadi MA\, McGettrick AF\, Mendez RS\, Zotta A\, Pea ce CG\, Walsh A\, Chirillo R\, Hams E\, Fallon PG\, Jayamaran R\, Dua K\, Brown AC\, Kim RY\, Horvat JC\, Hansbro PM\, Wang C\, O’Neill LAJ.Itaco nate and itaconate derivatives target JAK1 to suppress alternative activat ion of macrophages. Cell Metab. 2022 Mar 1\;34(3):487-501.e8. doi: 10.101 6/j.cmet.2022.02.002.\n\nHooftman A\, O’Neill LAJ.Nanoparticle asymmetr y shapes an immune response. Nature. 2022 Jan\;601(7893):323-325. doi: 10 .1038/d41586-021-03806-7.\n\n \; CATEGORIES:BiocityTurku events,Other events END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:STANDARD DTSTART:20221030T030000 TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET END:STANDARD END:VTIMEZONE END:VCALENDAR